Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in ...
PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...
Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...
Vishal A. Patel, MD, is an associate professor of dermatology at the GW School of Medicine & Health Sciences and the director ...
Discover effective strategies for monitoring and managing CRS toxicity and ICANS, enhancing patient care and reducing burdens ...
Experts discuss the importance of transitioning cancer care from academic centers to community settings, ensuring effective ...
Experts discuss the importance of transitioning cancer care from academic centers to community practices, ensuring patient ...
MicroRNAs are central regulators of DLBCL biology and show strong potential as minimally invasive biomarkers to improve ...
Panelist and director of the leukemia program at Massachusetts General Hospital, Amir Fathi, MD, explained that catchment ...
MASLD/MASH represents a growing clinical and economic burden, with MASH conferring heightened risks of advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related mortality. Noninvasive ...
With medically integrated dispensing (MID) models, pharmacists are more embedded in care and engage more frequently with patients, according to Kenneth Komorny, PharmD, BCPS, of Moffitt Cancer Center.
Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care. Medically integrated dispensing (MID) has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results